Yemaachi Biotech develops next-generation cancer drugs by creating and leveraging a comprehensive cancer knowledge base focused on diverse populations. The company pioneers clinical genomic research across Africa to diversify and improve precision oncology outcomes globally. This work aims to transform lives through inclusive, innovative science in cancer treatment.
Funding
$3.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cancer drug development often overlooks the genetic diversity within African populations, leading to treatments that may be less effective for individuals of African descent. Existing cancer knowledge bases lack sufficient representation of African genomic data, hindering the development of targeted therapies for these populations.
Solution
Yemaachi leverages immunogenomics, bioinformatics, and artificial intelligence to build a comprehensive cancer knowledge base that incorporates diverse African genomic data. This knowledge base is used to develop novel cancer therapeutics specifically designed to be effective in diverse populations. By pioneering clinical genomic research across Africa, Yemaachi aims to improve cancer detection and treatment strategies, ultimately transforming lives through inclusive, innovative science. The company's approach focuses on creating the next generation of cancer drugs that address the unique genetic profiles found in African populations.
Target Audience
Yemaachi's primary target audience includes pharmaceutical companies, research institutions, and healthcare providers focused on developing and delivering effective cancer treatments for diverse populations, particularly those of African descent.
Features
- Clinical genomic research across Africa across multiple cancer types
- Utilizes immunogenomics, bioinformatics, and artificial intelligence
- Development of cancer therapeutics effective in diverse populations
- Creation of a comprehensive cancer knowledge base with African genomic data